Aegerion Placed Under Supervision In Misbranding Settlement
A federal judge on Friday appointed a special master to keep a watchful eye on Aegerion Pharmaceuticals Inc. as it faces court-ordered audits and the payment of $36 million to patients...To view the full article, register now.
Already a subscriber? Click here to view full article